Atrial fibrillation and stroke: prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire community stroke project).
P Sandercock, J Bamford, M Dennis...
https://pubmed.ncbi.nlm.nih.gov/1493391/Actively Recruiting
Led by Vestre Viken Hospital Trust · Updated on 2024-11-05
410
Participants Needed
1
Research Sites
313 weeks
Total Duration
Researchers are investigating atrial fibrillation AF, a common heart rhythm problem linked to 20-30% of all strokes. Detecting AF early after a stroke is important because AF-related strokes tend to be more severe, but the best timing and devices for screening are not yet well defined. This study aims to find out if screening for AF right after stroke symptoms begin detects more cases than screening after hospital discharge and whether a 3-lead ECG device improves detection compared to a 1-lead patch recorder. The study involves patients admitted with acute stroke who do not have AF at admission or have paroxysmal AF but show normal heart rhythm when admitted. Participants will receive 48 hours of continuous heart monitoring in the hospital, followed by another 48 hours after discharge. A subgroup will also perform intermittent handheld ECG recordings three times daily for 30 seconds over three days during their hospital stay. The study compares continuous versus intermittent monitoring and different device types to see which detects AF more effectively. During their participation, patients will undergo heart rhythm monitoring with ECG devices and complete handheld ECG tests if selected. Researchers will track AF detection rates during 48 to 96 hours post-stroke, comparing results based on timing and device type. The study evaluates outcomes like the rate of AF detection with different monitoring strategies, aiming to improve early diagnosis to help prevent recurrent strokes. Participation includes monitoring during hospital stay and after discharge, with follow-up lasting up to about four days of recording.
CONDITIONS
SCREENING AFTER STROKE - ATRIAL FIBRILLATION
H
Håkon Ihle-Hansen, MD PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Vestre Viken Hospital Trust
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for screening and enrollment
Duration - 48 hours
Participants undergo initial heart monitoring to detect atrial fibrillation after acute stroke.
Continuous in-hospital monitoring for 48 hours
Duration - 48 hours
Participants continue heart monitoring after discharge to detect atrial fibrillation.
Ambulatory continuous heart monitoring for 48 hours post-discharge
Duration - 3 days
A sample of participants perform intermittent ECG monitoring using a hand-held device during hospital stay.
Intermittent thumb ECG recordings 3 times daily for 30 seconds during hospital stay
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
P Sandercock, J Bamford, M Dennis...
https://pubmed.ncbi.nlm.nih.gov/1493391/Walter N Kernan, Bruce Ovbiagele, Henry R Black...
https://pubmed.ncbi.nlm.nih.gov/24788967/W B Kannel, R D Abbott, D D Savage...
https://pubmed.ncbi.nlm.nih.gov/7062992/Hans T H Tu, Bruce C V Campbell, Soren Christensen...
https://pubmed.ncbi.nlm.nih.gov/23489996/Hooman Kamel, Kennedy R Lees, Patrick D Lyden...
https://pubmed.ncbi.nlm.nih.gov/19900647/Gerhard Hindricks, Tatjana Potpara, Nikolaos Dagres...
https://pubmed.ncbi.nlm.nih.gov/32860505/Sumeet S Chugh, Rasmus Havmoeller, Kumar Narayanan...
https://pubmed.ncbi.nlm.nih.gov/24345399/Vestre Viken Hospital Trust
Lead Sponsor